Dylan’s bedaquline paper one of the most read in Microbial Genomics in September! Philip Fowler, 20th October 202520th October 2025 Received a lovely email from Dr Peter Cotgreave who is the Chief Executive of the Microbiological Society to say Dylan’s manuscript where he created a resistance catalogue for bedaquiline was one of the most viewed papers in Microbial Genomics during September. Never had that before, but a nice surprise! Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related publication research tuberculosis
antimicrobial resistance Research position advertised 26th January 202126th January 2021 Come and work with me on antimicrobial resistance! Advert here. Broadly the idea is to… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
publication New Publication: Proteins Alter the Stiffness of Membranes 23rd September 201629th September 2018 Although there have been many studies of proteins whose primary function is to ‘sculpt’ the… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance New Publication: Predicting whether mutations confer resistance to an antibiotic 5th January 201829th September 2018 Due to the rise of antibiotic resistance, it is increasingly important that your clinician knows… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More